Inventor · disambiguated record
Frederic Vaillancourt
Also filed as: VAILLANCOURT FREDERIC
0 granted patents·24 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
24 records- 0162US2024226098A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0262US2024190879A1Fused bicyclic compounds useful for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0362US2023365566A1Heterocyclic amides and their use for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0460US2025109140A15-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPUTICS INC·Filed 2023·Application pending·0 cites
- 0559US2025082633A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0659US2023365526A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0759US2023140983A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0859US2025326748A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0959US2025092065A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1058US2024287097A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1158US2023159496A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1258US2024366612A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1358US2024279239A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1458US2025332173A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1557US2024400584A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1657US2024409536A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1757US2024368163A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1857US2025333397A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1957US2025154169A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2057US2023167093A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2152US2024239811A15-(5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the tREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2252US2024002375A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2349US2023148184A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2448US2023142338A1Thiophenyl derivatives useful for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederic Vaillancourt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →